Pharma Giants to Explore AI in Drug Discovery in Webinar Series
Three leading pharmaceutical companies, AstraZeneca, Pfizer, and Novartis, are set to participate in a series of workshops titled 'Transforming Drug Discovery with AI', taking place on October 7, 14, and 21, 2025. Sponsored by ENPICOM, these webinars aim to provide practical insights into the application of AI in drug discovery. The series kicks off with 'Beyond the AI Models: What It Really Takes to Deploy AI for Drug Discovery', focusing on operationalising AI in drug discovery. Topics will include data quality, resilient infrastructure, and cross-functional collaboration. The second webinar, 'Bridging Algorithms and Assays: AI Across the Drug Discovery Pipeline', will delve into the application of AI models in pipelines, human expert curation, and common pitfalls. The final webinar, 'Building Scalable and Efficient Drug Discovery Workflows', will centre around building scalable AI systems, harnessing multi-modal datasets, and implementing strategies for widespread adoption. Key takeaways will include understanding the deployment of AI tools in complex R&D environments and exploring the use of foundation and generative models in drug discovery. Notably, registration for the first webinar grants access to all subsequent webinars and on-demand recordings. The 'Transforming Drug Discovery with AI' webinar series, sponsored by ENPICOM, offers a comprehensive exploration of AI's role in drug discovery. With AstraZeneca, Pfizer, and Novartis involved, and topics ranging from operationalising AI to building scalable workflows, the series promises valuable insights for those in the field.
Read also:
- BMW's Debrecen Plant Unveiled: Birthplace of the iX3 and New Class Models
- Mapbox's Navigation Software Development Kit integrated with MapGT's Artificial Intelligence Voice Assistant
- US President Trump and UK Labour Leader Starmer discuss strengthening economic and technological ties between the United States and the United Kingdom.
- Leakage in Elon Musk's xAI Project Emerges
